A nationwide periguard ointment recall has triggered concern among patients, clinicians, and supply chain partners. Regulators and the manufacturer issued the alert after detecting deviations in sterility assurance during routine quality checks.
This overview explains what triggered the recall, how to identify affected batches, and what steps to take if you have the product on site or in inventory.
| Aspect | Details | Key Reference | Recommended Action |
|---|---|---|---|
| Product Name | PeriGuard Ointment | Label and Carton | Confirm NDC and lot number |
| Recall Class | Class II | Regulatory notice | Review risk level and urgency |
| Reason | Sterility assurance deviation | Quality investigation report | Isolate and quarantine stock |
| Distribution Scope | National, multiple channels | Regulatory filings | Trace inventory and customers |
Identifying Affected PeriGuard Ointment Batches
The recall focuses on specific lot numbers and expiration dates linked to the sterility concern. Not all production runs are impacted, and targeted removal helps reduce unnecessary disruptions.
Lot Identification and Packaging Features
Clinics, pharmacies, and facilities should compare lot codes on returned packaging against the official recall list. Carton labels, inner seals, and carton printing must all be checked for consistency.
Immediate Response and Quarantine Procedures
Healthcare institutions and distribution centers should immediately pause use and move recalled stock to a secure quarantine area. Segregating these units prevents accidental administration and supports accurate reporting.
Inventory Segregation and Documentation
Maintain a log capturing lot numbers, receipt dates, and current locations. Cross reference this log with recall communications from the supplier and regulatory authority to ensure completeness.
Clinical Guidance and Patient Management
Clinicians reviewing patient charts should verify whether any treatments involved recalled ointment batches. If exposure occurred, document details and coordinate follow up based on risk assessment and institutional protocols.
Risk Evaluation and Communication
Facilities should evaluate patient exposure scenarios, notify relevant departments, and align with clinical governance teams on appropriate next steps. Transparent communication with patients supports trust and safety.
Supply Chain Coordination and Reporting
Distributors and manufacturers must synchronize recall notices across warehouses, transport partners, and retail outlets. Centralized tracking tools help monitor withdrawal progress and prevent stock discrepancies.
Traceability and Corrective Measures
Implementing targeted audits and supplier reviews reinforces long term sterility assurance. Corrective actions should address root causes, such as process controls, equipment calibration, and staff training.
Strengthening Sterility Controls and Preventive Practices
Ongoing vigilance and structured procedures help maintain medication integrity and reduce future recall likelihood. Clear policies and training support consistent execution.
- Verify lot numbers and expiration dates against recall lists at receipt and before dispensing
- Quarantine affected stock and follow documented recall procedures promptly
- Coordinate with suppliers for replacement units and updated documentation
- Conduct internal audits to confirm adherence to sterility handling standards
- Maintain open communication channels with clinicians and patients regarding safety updates
FAQ
Reader questions
How can I confirm whether a specific tube is part of the recall?
Check the lot number and expiration date on the packaging against the official recall list published by the manufacturer or regulatory agency.
What should I do if the recalled ointment was already used on a patient?
Document the exposure, notify your clinical governance or pharmacy team, and follow institution specific risk assessment and monitoring protocols.
Does a Class II recall mean the product is unsafe in all uses?
Class II indicates a potential for temporary or reversible health consequences, and the recall targets specific batches rather than condemning every unit of the product.
Will replacement stock be available while recalled lots are withdrawn?
Manufacturers typically coordinate replacement supply for impacted customers once validated alternative batches are confirmed and released.